Medical Device News Magazine

Arsenal Acquires Automation Solutions Provider Eckhart from LFM Capital

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Arsenal Capital Partners (“Arsenal”), a private equity firm that specializes in investments in industrial growth and healthcare companies, today announced that it has acquired Eckhart Holdings, Inc. (“Eckhart”), a leading automation solutions provider from LFM Capital. Terms of the transaction were not disclosed.

Eckhart’s advanced engineering, design, simulation, and integration services, along with proprietary tooling and other automation and robotics systems, support customers at critical points in the automation value chain. Eckhart partners with blue-chip customers to design and implement automation solutions that solve complex problems and improve accuracy and efficiency in a number of attractive end markets, including ecommerce, engineered products, electric vehicles, transportation, and consumer products.

Andy Storm, CEO of Eckhart, commented, “We are excited to announce this strategic growth investment from Arsenal, which will enable us to take our business to new heights, scale our team, and better serve our customers. Arsenal’s extensive knowledge of the sector and track record of building high-growth, innovation-rich industrial technology businesses gave us confidence that they are the right partner.”

Aaron Wolfe, an Investment Partner of Arsenal, said, “We are thrilled to work closely with Eckhart’s senior leadership team to support a world-class automation platform in its next phase of growth. Eckhart’s solutions are critical to driving higher productivity, efficiency and precision, which is increasingly more valuable as customers compete on a global scale. Arsenal plans to invest a significant amount of incremental capital to accelerate growth, augment the solution set, and further penetrate attractive end markets.”

Daniel Burseth, Vice President of Eckhart, remarked, “The partnership with Arsenal comes at an opportune time as our customers invest at a record rate in automation for their operations. With Arsenal’s industrial track record and continued investment in expanding capabilities, Eckhart will become an even more important partner to a global customer base.”

Sal Gagliardo, an Operating Partner of Arsenal, added, “As systems increase in complexity, the design and integration of automation solutions becomes essential to efficient operations. We see significant opportunity ahead to leverage our collective industry expertise and deep financial resources to make Eckhart a clear innovation leader. As a firm, Arsenal will continue to invest in automation megatrends.

William Blair & Company L.L.C. served as financial advisor to Eckhart and LFM Capital on this transaction, and Bass, Berry & Sims PLC served as legal advisor to Eckhart and LFM. Harris Williams LLC served as financial advisor to Arsenal, and Kirkland & Ellis LLP served as legal advisor to Arsenal.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”